X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with Merck Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs MERCK LTD - Comparison Results

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS MERCK LTD DR. DATSONS LABS/
MERCK LTD
 
P/E (TTM) x -10.9 46.4 - View Chart
P/BV x 0.2 6.8 2.4% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   MERCK LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
MERCK LTD
Dec-17
DR. DATSONS LABS/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1261,358 9.3%   
Low Rs31933 3.3%   
Sales per share (Unadj.) Rs133.0665.0 20.0%  
Earnings per share (Unadj.) Rs0.256.6 0.3%  
Cash flow per share (Unadj.) Rs6.672.5 9.1%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs128.8441.7 29.2%  
Shares outstanding (eoy) m31.6616.60 190.7%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.61.7 34.2%   
Avg P/E ratio x516.120.2 2,549.5%  
P/CF ratio (eoy) x11.815.8 74.9%  
Price / Book Value ratio x0.62.6 23.4%  
Dividend payout %026.5 0.0%   
Avg Mkt Cap Rs m2,47719,011 13.0%   
No. of employees `000NA1.5 0.0%   
Total wages/salary Rs m561,696 3.3%   
Avg. sales/employee Rs ThNM7,150.0-  
Avg. wages/employee Rs ThNM1,098.7-  
Avg. net profit/employee Rs ThNM608.2-  
INCOME DATA
Net Sales Rs m4,21111,040 38.1%  
Other income Rs m79240 32.8%   
Total revenues Rs m4,28911,279 38.0%   
Gross profit Rs m5691,376 41.3%  
Depreciation Rs m204264 77.4%   
Interest Rs m4300-   
Profit before tax Rs m131,352 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0170 0.0%   
Tax Rs m6583 1.0%   
Profit after tax Rs m5939 0.5%  
Gross profit margin %13.512.5 108.3%  
Effective tax rate %48.043.1 111.4%   
Net profit margin %0.18.5 1.3%  
BALANCE SHEET DATA
Current assets Rs m6,8527,523 91.1%   
Current liabilities Rs m6,7112,253 297.9%   
Net working cap to sales %3.347.7 7.0%  
Current ratio x1.03.3 30.6%  
Inventory Days Days16152 308.4%  
Debtors Days Days31841 785.3%  
Net fixed assets Rs m3,6731,240 296.3%   
Share capital Rs m317166 190.7%   
"Free" reserves Rs m3,7617,167 52.5%   
Net worth Rs m4,0787,333 55.6%   
Long term debt Rs m1,6710-   
Total assets Rs m12,6339,912 127.4%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.1 29.9%   
Return on assets %3.49.5 36.3%  
Return on equity %0.112.8 0.9%  
Return on capital %7.720.8 37.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9641,015 95.0%   
Fx outflow Rs m6073,043 20.0%   
Net fx Rs m357-2,028 -17.6%   
CASH FLOW
From Operations Rs m1,345537 250.6%  
From Investments Rs m-2,256-476 473.6%  
From Financial Activity Rs m-1,200-220 545.9%  
Net Cashflow Rs m-2,111-160 1,323.3%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 0.0 18.2 -  
FIIs % 1.4 1.0 135.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 29.1 323.4%  
Shareholders   20,807 28,591 72.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  AUROBINDO PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Brexit Deal; Key Q2FY19 Results & Top Stocks in Focus Today(Pre-Open)

On Thursday, Indian share markets ended marginally higher led by bank stocks and finance stocks. At the closing bell, the BSE Sensex ended up by 119 points.

Related Views on News

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

Which Equity Mutual Funds to Buy Now?(Outside View)

Nov 13, 2018

PersonalFN explains that in falling markets investing in equity mutual funds can be beneficial in long run by choosing the right equity mutual fund scheme.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS